Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

During the Trading Day
272.34 +6.04 / +2.27%
As of 4:01pm ET
Day’s Change
During After-Hours   Switch to standard view »
272.34 0.00 / 0.00%
 
Volume: 17.5K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Operating ActivitiesNet Income / Starting Line-732.9M-512.3M-241.6M5.3B
 
 
 
 
 
Depreciation938.0M982.6M1.7B1.2B
 
 
 
 
 
Total Other Cash Flow861.7M781.0M961.8M1.2B
 
 
 
 
 
Funds From Operations789.2M947.0M2.2B896.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-22.4M422.0M783.1M-152.1M
 
 
 
 
 
Net Cash Flow - Operating Activities811.6M525.0M1.4B1.0B
 
 
 
 
 
 
InvestingIncrease In Investments-1.0M-15.0M-6.0M-6.0M
 
 
 
 
 
Decrease In Investments10.5M----0.00
 
 
Capital Expenditures-64.5M-136.6M-111.6M-102.5M
 
 
 
 
 
Fixed Asset Disposal1.7M74.9M6.6M52.1M
 
 
 
 
 
Net Assets From Acquisitions -639.7M-34.6B-463.7M-132.8M
 
 
 
 
 
Other Investing - Sources-9.5M790.5M65.3M0.00
 
 
 
 
Net Cash Flow Investing-738.5M-33.9B-529.4M-251.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.00--------
Long Term Borrowings1.0B29.0B72.8M0.00
 
 
 
 
Long Term Debt Reduction-1.3B-2.7B-1.4B-230.5M
 
 
 
 
 
Net Proceeds Stock Sale62.6M9.0B65.6M87.6M
 
 
 
 
 
Common Preferred Redeemed-30.4M-64.1M-36.9M-7.2M
 
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.00-68.7M-69.7M
 
 
 
Other Sources - Financing28.4M36.1M200.0K17.7M
 
 
 
 
 
Other Uses - Financing1.7M24.6M67.4M46.3M
 
 
 
 
 
Net Cash Flow - Financing-158.7M35.3B-1.5B-248.4M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-3.8M-4.8M1.7M-2.0M
 
 
 
 
 
 
Net Change In Cash-85.6M1.9B-598.7M548.0M